{"id":"https://openalex.org/W2154256486","doi":"https://doi.org/10.1038/oby.2009.155","title":"Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo\u2010controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)","display_name":"Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo\u2010controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-21","ids":{"openalex":"https://openalex.org/W2154256486","doi":"https://doi.org/10.1038/oby.2009.155","mag":"2154256486","pmid":"https://pubmed.ncbi.nlm.nih.gov/19461584"},"language":"en","primary_location":{"id":"doi:10.1038/oby.2009.155","doi":"https://doi.org/10.1038/oby.2009.155","is_oa":false,"landing_page_url":"https://doi.org/10.1038/oby.2009.155","pdf_url":null,"source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2154256486"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113868689","display_name":"Peter G Kopelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Kopelman","raw_affiliation_strings":["St Georges, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Georges, University of London, London, UK","institution_ids":["https://openalex.org/I165862685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065738904","display_name":"H. Gerrit de Groot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138925","display_name":"Nederlandse Obesitas Kliniek","ror":"https://ror.org/04e53cd15","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210138925"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H. Gerrit de Groot","raw_affiliation_strings":["Nederlandse Obesitas Kliniek, Hilversum, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nederlandse Obesitas Kliniek, Hilversum, Netherlands","institution_ids":["https://openalex.org/I4210138925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104085781","display_name":"Aila Rissanen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aila Rissanen","raw_affiliation_strings":["Obesity Reserach Unit, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Obesity Reserach Unit, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059778565","display_name":"Stephan R\u00f6ssner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Stephan Rossner","raw_affiliation_strings":["Karolinska University Hospital Huddinge, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska University Hospital Huddinge, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109127953","display_name":"S\u00f8ren Toubro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801942218","display_name":"Hvidovre Hospital","ror":"https://ror.org/00edrn755","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801942218","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Soren Toubro","raw_affiliation_strings":["Hvidovre Hospital, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hvidovre Hospital, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2801942218"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Palmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266994","display_name":"Alizyme PLC (United Kingdom)","ror":"https://ror.org/00ps4k811","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405266994"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Palmer","raw_affiliation_strings":["Alizyme Therapeutics Ltd., Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alizyme Therapeutics Ltd., Cambridge, UK","institution_ids":["https://openalex.org/I4405266994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090025105","display_name":"Rob Hallam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266994","display_name":"Alizyme PLC (United Kingdom)","ror":"https://ror.org/00ps4k811","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405266994"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rob Hallam","raw_affiliation_strings":["Alizyme Therapeutics Ltd., Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alizyme Therapeutics Ltd., Cambridge, UK","institution_ids":["https://openalex.org/I4405266994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113495476","display_name":"Andrew L. Bryson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266994","display_name":"Alizyme PLC (United Kingdom)","ror":"https://ror.org/00ps4k811","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405266994"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew Bryson","raw_affiliation_strings":["Alizyme Therapeutics Ltd., Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alizyme Therapeutics Ltd., Cambridge, UK","institution_ids":["https://openalex.org/I4405266994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112442683","display_name":"Roger I. Hickling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266994","display_name":"Alizyme PLC (United Kingdom)","ror":"https://ror.org/00ps4k811","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405266994"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roger I. Hickling","raw_affiliation_strings":["Alizyme Therapeutics Ltd., Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alizyme Therapeutics Ltd., Cambridge, UK","institution_ids":["https://openalex.org/I4405266994"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5113495476"],"corresponding_institution_ids":["https://openalex.org/I4405266994"],"apc_list":{"value":4980,"currency":"USD","value_usd":4980},"apc_paid":null,"fwci":4.9936,"has_fulltext":false,"cited_by_count":111,"citation_normalized_percentile":{"value":0.94856405,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"18","issue":"1","first_page":"108","last_page":"115"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9089999794960022},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9739999771118164},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.859000027179718},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9869999885559082},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.765999972820282},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7390000224113464},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8740000128746033},{"id":"https://openalex.org/keywords/lipase-inhibitors","display_name":"lipase inhibitors","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C2780780548","wikidata":"https://www.wikidata.org/wiki/Q424163","display_name":"Orlistat","level":4,"score":0.9395320415496826},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8471686244010925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8052485585212708},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7879253029823303},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6341931819915771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6135606169700623},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5556210279464722},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5049338936805725},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4918782711029053},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.48814472556114197},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.4285028874874115},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4284785985946655},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4154930114746094},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.40213072299957275},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.31659579277038574},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.2696342468261719},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21809768676757812},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.18835198879241943},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077403","descriptor_name":"Orlistat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008049","descriptor_name":"Lipase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D057194","descriptor_name":"Intention to Treat Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/oby.2009.155","doi":"https://doi.org/10.1038/oby.2009.155","is_oa":false,"landing_page_url":"https://doi.org/10.1038/oby.2009.155","pdf_url":null,"source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},{"id":"pmid:19461584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19461584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity (Silver Spring, Md.)","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W48920773","https://openalex.org/W1422618495","https://openalex.org/W1907290811","https://openalex.org/W1939662740","https://openalex.org/W1964227153","https://openalex.org/W1967220509","https://openalex.org/W1975588287","https://openalex.org/W1991138114","https://openalex.org/W2012943708","https://openalex.org/W2015605491","https://openalex.org/W2030630495","https://openalex.org/W2032907323","https://openalex.org/W2041411684","https://openalex.org/W2048083913","https://openalex.org/W2104675089","https://openalex.org/W2106623465","https://openalex.org/W2108606500","https://openalex.org/W2138810608","https://openalex.org/W2144598225","https://openalex.org/W2604976832","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2015747658","https://openalex.org/W2060268563","https://openalex.org/W2048083913","https://openalex.org/W2143145348","https://openalex.org/W1991138114","https://openalex.org/W2057956489","https://openalex.org/W2126177048","https://openalex.org/W2351592493","https://openalex.org/W1571263873"],"abstract_inverted_index":{"The":[0,57],"objective":[1],"of":[2,15,73,229],"this":[3],"multicenter,":[4],"randomized,":[5],"double-blind":[6],"study":[7],"was":[8,60,149,173,186,223],"to":[9,20,38,157,189,216,232,236],"determine":[10],"the":[11,121,163,170,178,227],"efficacy":[12],"and":[13,17,75,125,135,152,165,182,185,211],"safety":[14],"cetilistat":[16,40,88,181,195],"orlistat":[18,50,166,171,203],"relative":[19,215],"placebo":[21,104,126,164,183,217],"in":[22,63,80,85,142,162,169,177,218],"obese":[23,219],"patients":[24,35,86],"with":[25,194,202,226],"type":[26],"2":[27],"diabetes,":[28],"on":[29],"metformin.":[30],"Following":[31],"a":[32],"2-week":[33],"run-in,":[34],"were":[36,83,101,129,146],"randomized":[37],"placebo,":[39],"(40,":[41],"80,":[42],"or":[43,49,90,94,197,201],"120":[44,51,91,95,179,198,204],"mg":[45,52,92,96,123,180,199,205],"three":[46],"times":[47],"daily),":[48],"t.i.d.,":[53,200,206],"for":[54],"12":[55],"weeks.":[56],"primary":[58],"endpoint":[59],"absolute":[61],"change":[62],"body":[64,81,209],"weight":[65,82,210],"from":[66],"baseline.":[67],"Secondary":[68],"endpoints":[69],"included":[70],"other":[71],"measures":[72],"obesity":[74],"glycemic":[76,213],"control.":[77],"Similar":[78],"reductions":[79,100,128,141],"observed":[84],"receiving":[87],"80":[89,196],"t.i.d.":[93,97,124],"orlistat;":[98],"these":[99],"significant":[102,140],"vs.":[103],"(3.85":[105],"kg,":[106,111,116,131,137],"P":[107,112,117,132],"=":[108,113,118,133],"0.01;":[109],"4.32":[110],"0.0002;":[114],"3.78":[115],"0.008).":[119],"In":[120],"40":[122],"groups,":[127],"2.94":[130],"0.958":[134],"2.86":[136],"respectively.":[138],"Statistically":[139],"glycosylated":[143],"hemoglobin":[144],"(HbA(1c))":[145],"noted.":[147],"Cetilistat":[148,222],"well":[150,224],"tolerated,":[151],"showed":[153],"fewer":[154],"discontinuations":[155,230],"due":[156,188,231],"adverse":[158],"events":[159],"(AEs)":[160],"than":[161,176],"groups.":[167],"Discontinuation":[168],"group":[172],"significantly":[174,207],"worse":[175],"groups":[184],"entirely":[187],"gastrointestinal":[190],"(GI)":[191],"AEs.":[192],"Treatment":[193],"reduced":[208],"improved":[212],"control":[214],"diabetic":[220],"patients.":[221],"tolerated":[225],"number":[228],"AEs":[233],"being":[234],"similar":[235],"placebo.":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2154256486","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
